OR WAIT null SECS
June 27, 2024
This $4.1 billion investment to build a second fill/finish manufacturing facility in Clayton, N.C., boosts Novo Nordisk's current 2024 investments in production to $6.8 billion.
May 30, 2024
Lilly’s investment increase is intended to boost manufacturing capacity at its Lebanon, Ind., site for APIs used in the production of tirzepatide and other pipeline drug candidates.
April 22, 2024
Mary Van Gaasbeck, technical services specialist, LS Equipment and Services, at STERIS Life Sciences, notes that automation is key when it comes to effective sterile powder transfer of parenteral drug products.
March 02, 2024
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
February 15, 2024
The company’s Itasca, Ill., facility will offer chemistry, manufacturing, and controls analytical testing support.
October 02, 2023
The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
September 29, 2023
Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.
November 02, 2022
Gerresheimer and Nelson Labs will work together to conduct extractables and leachables testing on upcoming primary packaging solutions.
October 21, 2022
Recipharm’s new high speed filling line, designed for pre-filled syringes and cartridges, is expected to be operational by May 2023.
May 26, 2022
Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.